Review



mouse mpo elisa  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    R&D Systems mouse mpo elisa
    Mouse Mpo Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 136 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+mpo+elisa/Mouse+Myeloperoxidase+DuoSet+ELISA/us12611414-302-14-17
    Average 95 stars, based on 136 article reviews
    mouse mpo elisa - by Bioz Stars, 2026-08
    95/100 stars

    Images



    Similar Products

    mouse myeloperoxidase/mpo elisa kit  (Multi Sciences (Lianke) Biotech Co Ltd)
    94
    Multi Sciences (Lianke) Biotech Co Ltd mouse myeloperoxidase/mpo elisa kit
    Mouse Myeloperoxidase/Mpo Elisa Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+mpo+elisa/Mouse+myeloperoxidase%2FMPO+ELISA+Kit/custom%40ek2133%4041866771
    Average 94 stars, based on 1 article reviews
    mouse myeloperoxidase/mpo elisa kit - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    mouse mpo elisa  (R&D Systems)
    95
    R&D Systems mouse mpo elisa
    Mouse Mpo Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+mpo+elisa/Mouse+Myeloperoxidase+DuoSet+ELISA/us12611414-302-14-17
    Average 95 stars, based on 1 article reviews
    mouse mpo elisa - by Bioz Stars, 2026-08
    95/100 stars
    		  Buy from Supplier
    mouse mpo elisa kit  (Hycultec Inc)
    86
    Hycultec Inc mouse mpo elisa kit
    Mouse Mpo Elisa Kit, supplied by Hycultec Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+mpo+elisa/elisa+kit+mouse+mpo/pm42041574-106-33-37
    Average 86 stars, based on 1 article reviews
    mouse mpo elisa kit - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    myeloperoxidase mpo  (Multi Sciences (Lianke) Biotech Co Ltd)
    94
    Multi Sciences (Lianke) Biotech Co Ltd myeloperoxidase mpo
    AEAA pretreatment is associated with reduced pathological features of LPS-induced acute lung injury in mice. (A) Experimental design of the LPS-induced acute lung injury (ALI) model. (B) Histopathological evaluation of lung tissues. Representative H&E-stained sections from different treatment groups at 20× and 40× magnification show alveolar wall thickening, inflammatory cell infiltration, hemorrhage, and edema in LPS-treated mice. AEAA treatment dose-dependently ameliorated these pathological alterations (red boxed areas). (C) Wet-to-dry (W/D) lung weight ratio. (D) Lung injury score. (E–G) Pro-inflammatory cytokines in serum and BALF.IL-1β (E) , IL-6 (F) , and IL-10 (G) levels in serum and BALF. (H) TNF-α levels in serum and BALF. (I) <t>Myeloperoxidase</t> <t>(MPO)</t> activity. Data are presented as mean ± SEM. n = 5 per group. Statistical analysis was performed using one-way ANOVA followed by post hoc tests. * P < 0.05 , ** P < 0.01 , *** P < 0.001 , **** P < 0.0001 .
    Myeloperoxidase Mpo, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+mpo+elisa/Mouse+myeloperoxidase%2FMPO+ELISA+Kit/pmc13082973-61-20-27
    Average 94 stars, based on 1 article reviews
    myeloperoxidase mpo - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    elisa kits for mpo  (Multi Sciences (Lianke) Biotech Co Ltd)
    94
    Multi Sciences (Lianke) Biotech Co Ltd elisa kits for mpo
    AEAA pretreatment is associated with reduced pathological features of LPS-induced acute lung injury in mice. (A) Experimental design of the LPS-induced acute lung injury (ALI) model. (B) Histopathological evaluation of lung tissues. Representative H&E-stained sections from different treatment groups at 20× and 40× magnification show alveolar wall thickening, inflammatory cell infiltration, hemorrhage, and edema in LPS-treated mice. AEAA treatment dose-dependently ameliorated these pathological alterations (red boxed areas). (C) Wet-to-dry (W/D) lung weight ratio. (D) Lung injury score. (E–G) Pro-inflammatory cytokines in serum and BALF.IL-1β (E) , IL-6 (F) , and IL-10 (G) levels in serum and BALF. (H) TNF-α levels in serum and BALF. (I) <t>Myeloperoxidase</t> <t>(MPO)</t> activity. Data are presented as mean ± SEM. n = 5 per group. Statistical analysis was performed using one-way ANOVA followed by post hoc tests. * P < 0.05 , ** P < 0.01 , *** P < 0.001 , **** P < 0.0001 .
    Elisa Kits For Mpo, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+mpo+elisa/Mouse+myeloperoxidase%2FMPO+ELISA+Kit/pm41833149-68-0-23
    Average 94 stars, based on 1 article reviews
    elisa kits for mpo - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    myeloperoxidase mpo  (R&D Systems)
    95
    R&D Systems myeloperoxidase mpo
    AEAA pretreatment is associated with reduced pathological features of LPS-induced acute lung injury in mice. (A) Experimental design of the LPS-induced acute lung injury (ALI) model. (B) Histopathological evaluation of lung tissues. Representative H&E-stained sections from different treatment groups at 20× and 40× magnification show alveolar wall thickening, inflammatory cell infiltration, hemorrhage, and edema in LPS-treated mice. AEAA treatment dose-dependently ameliorated these pathological alterations (red boxed areas). (C) Wet-to-dry (W/D) lung weight ratio. (D) Lung injury score. (E–G) Pro-inflammatory cytokines in serum and BALF.IL-1β (E) , IL-6 (F) , and IL-10 (G) levels in serum and BALF. (H) TNF-α levels in serum and BALF. (I) <t>Myeloperoxidase</t> <t>(MPO)</t> activity. Data are presented as mean ± SEM. n = 5 per group. Statistical analysis was performed using one-way ANOVA followed by post hoc tests. * P < 0.05 , ** P < 0.01 , *** P < 0.001 , **** P < 0.0001 .
    Myeloperoxidase Mpo, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+mpo+elisa/Mouse+Myeloperoxidase+DuoSet+ELISA/pm41812248-50-4-21
    Average 95 stars, based on 1 article reviews
    myeloperoxidase mpo - by Bioz Stars, 2026-08
    95/100 stars
    		  Buy from Supplier
    mpo ek0943  (Boster Bio)
    93
    Boster Bio mpo ek0943
    AEAA pretreatment is associated with reduced pathological features of LPS-induced acute lung injury in mice. (A) Experimental design of the LPS-induced acute lung injury (ALI) model. (B) Histopathological evaluation of lung tissues. Representative H&E-stained sections from different treatment groups at 20× and 40× magnification show alveolar wall thickening, inflammatory cell infiltration, hemorrhage, and edema in LPS-treated mice. AEAA treatment dose-dependently ameliorated these pathological alterations (red boxed areas). (C) Wet-to-dry (W/D) lung weight ratio. (D) Lung injury score. (E–G) Pro-inflammatory cytokines in serum and BALF.IL-1β (E) , IL-6 (F) , and IL-10 (G) levels in serum and BALF. (H) TNF-α levels in serum and BALF. (I) <t>Myeloperoxidase</t> <t>(MPO)</t> activity. Data are presented as mean ± SEM. n = 5 per group. Statistical analysis was performed using one-way ANOVA followed by post hoc tests. * P < 0.05 , ** P < 0.01 , *** P < 0.001 , **** P < 0.0001 .
    Mpo Ek0943, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+mpo+elisa/Mouse+MPO%2FMyeloperoxidase+ELISA+Kit+PicoKine/10__1002_slash_imo2__70090-225-12-17
    Average 93 stars, based on 1 article reviews
    mpo ek0943 - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    mpo  (Multi Sciences (Lianke) Biotech Co Ltd)
    94
    Multi Sciences (Lianke) Biotech Co Ltd mpo
    AEAA pretreatment is associated with reduced pathological features of LPS-induced acute lung injury in mice. (A) Experimental design of the LPS-induced acute lung injury (ALI) model. (B) Histopathological evaluation of lung tissues. Representative H&E-stained sections from different treatment groups at 20× and 40× magnification show alveolar wall thickening, inflammatory cell infiltration, hemorrhage, and edema in LPS-treated mice. AEAA treatment dose-dependently ameliorated these pathological alterations (red boxed areas). (C) Wet-to-dry (W/D) lung weight ratio. (D) Lung injury score. (E–G) Pro-inflammatory cytokines in serum and BALF.IL-1β (E) , IL-6 (F) , and IL-10 (G) levels in serum and BALF. (H) TNF-α levels in serum and BALF. (I) <t>Myeloperoxidase</t> <t>(MPO)</t> activity. Data are presented as mean ± SEM. n = 5 per group. Statistical analysis was performed using one-way ANOVA followed by post hoc tests. * P < 0.05 , ** P < 0.01 , *** P < 0.001 , **** P < 0.0001 .
    Mpo, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+mpo+elisa/Mouse+myeloperoxidase%2FMPO+ELISA+Kit/pm41699795-39-26-38
    Average 94 stars, based on 1 article reviews
    mpo - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    AEAA pretreatment is associated with reduced pathological features of LPS-induced acute lung injury in mice. (A) Experimental design of the LPS-induced acute lung injury (ALI) model. (B) Histopathological evaluation of lung tissues. Representative H&E-stained sections from different treatment groups at 20× and 40× magnification show alveolar wall thickening, inflammatory cell infiltration, hemorrhage, and edema in LPS-treated mice. AEAA treatment dose-dependently ameliorated these pathological alterations (red boxed areas). (C) Wet-to-dry (W/D) lung weight ratio. (D) Lung injury score. (E–G) Pro-inflammatory cytokines in serum and BALF.IL-1β (E) , IL-6 (F) , and IL-10 (G) levels in serum and BALF. (H) TNF-α levels in serum and BALF. (I) Myeloperoxidase (MPO) activity. Data are presented as mean ± SEM. n = 5 per group. Statistical analysis was performed using one-way ANOVA followed by post hoc tests. * P < 0.05 , ** P < 0.01 , *** P < 0.001 , **** P < 0.0001 .

    Journal: Frontiers in Immunology

    Article Title: Aqueous Artemisia argyi extract mitigates acute lung injury in association with coordinated alterations in gut microbiota, metabolic homeostasis, and pulmonary inflammatory gene expression

    doi: 10.3389/fimmu.2026.1770675

    Figure Lengend Snippet: AEAA pretreatment is associated with reduced pathological features of LPS-induced acute lung injury in mice. (A) Experimental design of the LPS-induced acute lung injury (ALI) model. (B) Histopathological evaluation of lung tissues. Representative H&E-stained sections from different treatment groups at 20× and 40× magnification show alveolar wall thickening, inflammatory cell infiltration, hemorrhage, and edema in LPS-treated mice. AEAA treatment dose-dependently ameliorated these pathological alterations (red boxed areas). (C) Wet-to-dry (W/D) lung weight ratio. (D) Lung injury score. (E–G) Pro-inflammatory cytokines in serum and BALF.IL-1β (E) , IL-6 (F) , and IL-10 (G) levels in serum and BALF. (H) TNF-α levels in serum and BALF. (I) Myeloperoxidase (MPO) activity. Data are presented as mean ± SEM. n = 5 per group. Statistical analysis was performed using one-way ANOVA followed by post hoc tests. * P < 0.05 , ** P < 0.01 , *** P < 0.001 , **** P < 0.0001 .

    Article Snippet: Enzyme-linked immunosorbent assay (ELISA) kits for mouse IL-1β (Cat. #EK201B), IL-6 (Cat. #EK206), IL-10 (Cat. #EK210), TNF-α (Cat. #EK282), and myeloperoxidase (MPO) (Cat. #EK2133) were obtained from Multisciences (Lianke) Biotech Co., Ltd. (Hangzhou, China).

    Techniques: Staining, Activity Assay